Home › Thermo Fisher Scientific Loans Premaitha $3M to Fund Litigation With Illumina

Thermo Fisher Scientific Loans Premaitha $3M to Fund Litigation With Illumina

Jan 22, 2018

NEW YORK (GenomeWeb) – UK prenatal diagnostics company Premaitha Health has received a £1.2 million ($3 million) loan from Thermo Fisher Scientific to cover legal costs related to its ongoing patent litigation with Illumina, the company said today.

Premaitha and Thermo Fisher entered into a secured loan facility agreement, which is secured on the shares of Premaitha's Taiwanese subsidiary, Yourgene Bioscience.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Nov
05
Featured Webinar

Overcoming Challenges in Solid Tumor Testing with Advanced AI

Sponsored by
Sophia Genetics

With the Next Generation Sequencing (NGS), genomes sequencing has been democratized over the last decades with the detection of genomic alterations, thus replacing Sanger sequencing.

What's Popular?

In Molecular Diagnostics

  1. Thermo Fisher Scientific Gets CE-IVD Mark for NGS Cancer Test

  2. Roche Patent Invalidation Affirmed in TB Testing Lawsuit Against Cepheid

  3. FDA Approves Myriad Genetics BRCA CDx With Pfizer's Metastatic Breast Cancer Drug

  4. Liquid Biopsy IDs More NSCLC Mutations, Yields Patient Therapy Response in Study of Guardant Test

  5. Abbott Q3 Dx Business Grows 43 Percent

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.